Impact of active surveillance on meticillin-resistant Staphylococcus aureus transmission and hospital resource utilisation
Introduction
Infection and colonisation with meticillin-resistant Staphylococcus aureus (MRSA) have been associated with significant morbidity and mortality.1, 2 The cost associated with treatment of hospital-acquired MRSA infections is higher relative to treating other less resistant bacteria such as meticillin-susceptible S. aureus.3, 4, 5 Finally, the increasing use of antimicrobial agents with activity against MRSA may be contributing to the emergence of more resistant pathogens such as vancomycin-intermediate-resistant S. aureus, vancomycin-resistant S. aureus, and vancomycin-resistant enterococcus.6, 7, 8
Infection prevention measures are thus necessary to decrease the spread of MRSA. Prior studies have shown conflicting results, making the utility of universal active surveillance cultures (ASCs) controversial.9 Recent practice recommendations from the Society for Healthcare Epidemiology of America and Infectious Diseases Society of America as well as the Centers for Disease Control and Prevention (CDC) advocate a tiered approach, reserving surveillance cultures for situations in which other infection control measures have not been successful and only in patients who are at high risk.10
Multiple advances have been made in infection control practices for MRSA. In 2006 the Keystone group developed an infection control bundle to reduce the incidence of bloodstream infections (BSIs). This BSI bundle, which was employed during insertion of central venous catheters, included hand washing, chlorhexidine skin preparation, full-barrier precautions, the avoidance of the femoral vein as an insertion site, and prompt removal of unnecessary central access sites. A ventilator-associated pneumonia (VAP) bundle has likewise been developed which included maintaining the head of the bed at 30 degrees, sedation vacation with daily weaning trials, peptic ulcer prophylaxis, deep venous thrombosis prophylaxis and tight glycaemic control.
The Henry Ford Health System is an integrated group of hospitals across southeastern Michigan that consists of one tertiary care teaching hospital in urban Detroit and a number of satellite urban and suburban community hospitals. MRSA has been endemic in this particular geographic area and has been complicated with therapeutic challenges due to the emergence of S. aureus strains with reduced susceptibility to vancomycin.6, 7, 8, 11, 12 To contain MRSA and eradicate nosocomial MRSA transmission is a major goal for infection control programmes. However, how best to do this remains unclear. Active surveillance cultures are a method to control MRSA transmission, but there remains no conclusion on how to proceed with it. The majority of studies on ASCs for MRSA were performed at tertiary care centres and may not be applicable to community hospitals.
This prospective cohort study was performed to evaluate the utility of adding ASCs for MRSA in the ICUs to standard infection prevention protocols in two different kinds of healthcare settings, a tertiary care hospital and a community-based hospital in the Henry Ford Health System located in southeastern Michigan.
Section snippets
Study design
We conducted a prospective cohort study to determine the utility of ASCs for MRSA on patients admitted to the ICUs in two hospitals. Hospital 1 is a 903-bed teaching facility located in Detroit, Michigan, with multi-organ transplant centre, level 1 trauma centre, and 124-bed ICU complex. The ICU complex is divided into medical, cardiac, surgical and neurosurgical units. The 16-bed cardiac ICU was excluded in the study due to low rate of MRSA infection. Hospital 2 is a 379-bed community hospital
Compliance data
BSI bundle compliance for both hospitals was consistently above 95% during the entire study period. VAP bundle compliance for both hospitals was above 85% with the exception of the month prior to the intervention period, during which compliance was recorded at less than 50% for hospital 2.
The hand-hygiene campaign started in December 2007 for both hospitals. Prior to the intervention period, hand-hygiene compliance was 60% or less for both. During the intervention period, hospital 1 was at or
Discussion
This prospective cohort study evaluated the effect of active MRSA surveillance on nosocomial infections, VAP and BSI. At the onset of the intervention period, hand hygiene was optimised and ASC was initiated. Patients who were found to be colonised with MRSA were placed in contact precautions. We found a significant reduction in the incidence of VAP in both the tertiary hospital and the community-based hospital as well as reduction in hospital-wide MRSA infections in the community-based
References (26)
Reducing methicillin-resistant Staphylococcus aureus (MRSA) infections
Jt Comm J Qual Patient Saf
(2007)- et al.
Effect of MRSA transmission of rapid PCR testing of patients admitted to critical care
J Hosp Infect
(2007) - et al.
The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database
Arch Intern Med
(2005) - et al.
The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals
Clin Infect Dis
(2008) - et al.
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis
Clin Infect Dis
(2003) - et al.
Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals
Infect Control Hosp Epidemiol
(2008) - et al.
SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus
Infect Control Hosp Epidemiol
(2003) - et al.
Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit
J Clin Microbiol
(2008) - et al.
Vancomycin-resistant Staphylococcus aureus in the Unites States, 2002–2006
Clin Infect Dis
(2008) Vancomycin-resistant Staphylococcus aureus: a perfect but geographically limited storm?
Clin Infect Dis
(2008)